Novavax (NVAX) Misses Q4 EPS by 5c
Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Novavax (NVAX) click here.
Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Novavax (NVAX) click here.